546 related articles for article (PubMed ID: 29547445)
1. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
[TBL] [Abstract][Full Text] [Related]
2. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
[TBL] [Abstract][Full Text] [Related]
3. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.
Roul H; Mary-Krause M; Ghosn J; Delaugerre C; Pialoux G; Cuzin L; Launay O; Lacombe JM; Menard A; De Truchis P; Delfraissy JF; Weiss L; Costagliola D;
AIDS; 2018 Nov; 32(17):2605-2614. PubMed ID: 30289817
[TBL] [Abstract][Full Text] [Related]
4. Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysis.
Inzaule SC; Kroeze S; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Steegen K; Nankya I; Boender TS; Ondoa P; Sigaloff KCE; de Wit TFR; Hamers RL
AIDS; 2022 Aug; 36(10):1437-1447. PubMed ID: 35608116
[TBL] [Abstract][Full Text] [Related]
5. Determinants of suboptimal immune recovery among a Chinese Yi ethnicity population with sustained HIV suppression.
Chen L; Liu CH; Kang S; Du L; Ma F; Li C; Bai L; Li H; Tang H
BMC Infect Dis; 2022 Feb; 22(1):137. PubMed ID: 35135485
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.
Worodria W; Ssempijja V; Hanrahan C; Ssegonja R; Muhofwa A; Mazapkwe D; Mayanja-Kizza H; Reynolds SJ; Colebunders R; Manabe YC
AIDS; 2018 Sep; 32(15):2141-2149. PubMed ID: 30005014
[TBL] [Abstract][Full Text] [Related]
7. Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania.
Stete K; Glass TR; van Dam GJ; Ntamatungiro A; Letang E; de Dood CJ; Corstjens PLAM; Ndege R; Mapesi H; Kern WV; Hatz C; Weisser M; Utzinger J; Müller MC
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006844. PubMed ID: 30332404
[TBL] [Abstract][Full Text] [Related]
8. Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression.
O'Connor JL; Smith CJ; Lampe FC; Hill T; Gompels M; Hay P; Chadwick D; Fisher M; Ainsworth J; Gilson R; Mackie N; Anderson J; Orkin C; Nelson M; Kegg S; Leen C; Palfreeman A; Post F; Johnson M; Sabin CA; Phillips AN;
AIDS; 2014 Mar; 28(6):919-24. PubMed ID: 24335482
[TBL] [Abstract][Full Text] [Related]
9. CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based data.
Kufa T; Shubber Z; MacLeod W; Takuva S; Carmona S; Bor J; Gorgens M; Pillay Y; Puren A; Eaton JW; Fraser-Hurt N
PLoS One; 2019; 14(5):e0217742. PubMed ID: 31150489
[TBL] [Abstract][Full Text] [Related]
10. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
[TBL] [Abstract][Full Text] [Related]
11. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
[TBL] [Abstract][Full Text] [Related]
12. Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.
Krogstad P; Patel K; Karalius B; Hazra R; Abzug MJ; Oleske J; Seage GR; Williams PL; Borkowsky W; Wiznia A; Pinto J; Van Dyke RB;
AIDS; 2015 Mar; 29(6):683-93. PubMed ID: 25849832
[TBL] [Abstract][Full Text] [Related]
13. The risk factors for suboptimal CD4 recovery in HIV infected population: an observational and retrospective study in Shanghai, China.
Zhang F; Sun M; Sun J; Guan L; Wang J; Lu H
Biosci Trends; 2015 Oct; 9(5):335-41. PubMed ID: 26559026
[TBL] [Abstract][Full Text] [Related]
14. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda.
Jain V; Byonanebye DM; Amanyire G; Kwarisiima D; Black D; Kabami J; Chamie G; Clark TD; Rooney JF; Charlebois ED; Kamya MR; Havlir DV;
AIDS; 2014 Sep; 28(15):2241-9. PubMed ID: 25022596
[TBL] [Abstract][Full Text] [Related]
15. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Makutu DK; Nfanyana K; Rantleru T; Tierney A; Nkakana K; Schwartz AB; Gross R; Macgregor RR; Bellamy SL; Frank I; Weissman D; Bisson GP
J Infect Dis; 2013 Dec; 208(11):1784-93. PubMed ID: 23908475
[TBL] [Abstract][Full Text] [Related]
16. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.
Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S;
HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667
[TBL] [Abstract][Full Text] [Related]
17. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
18. Immunologic response to antiretroviral therapy by age among treatment-naive patients in Sub-Saharan Africa.
Stafford KA; Magder LS; Hungerford LL; Guralnik JM; El-Kamary SS; Baumgarten M; Redfield RR
AIDS; 2018 Jan; 32(1):25-34. PubMed ID: 29028658
[TBL] [Abstract][Full Text] [Related]
19. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.
Nash D; Katyal M; Brinkhof MW; Keiser O; May M; Hughes R; Dabis F; Wood R; Sprinz E; Schechter M; Egger M;
AIDS; 2008 Nov; 22(17):2291-302. PubMed ID: 18981768
[TBL] [Abstract][Full Text] [Related]
20. Suboptimal immune recovery and associated factors among people living with HIV/AIDS on second-line antiretroviral therapy in central China: A retrospective cohort study.
Zhu K; Xu Q; Ma Y; Li P; Jia H; Jiang Q; Wang Y; Wu Z; Wang D; Guo H; Jin Y
J Med Virol; 2022 Oct; 94(10):4975-4982. PubMed ID: 35710693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
